Scientists Expose Deadly ‘Hot’ Batches of Covid ‘Vaccines’

An alarming new study has revealed that certain batches of Covid mRNA “vaccines” distributed among the American people had a far higher risk of causing adverse events and sudden deaths.

Scientists uncovered evidence revealing that some communities across the United States received “hot” batches of Pfizer-BioNTech Covid injections.

The shocking discovery was revealed in a peer-reviewed letter published in the renowned scientific journal Science, Public Health Policy and the Law.

The study was conducted by Children’s Health Defense (CHD) scientists Brian Hooker, Ph.D, and Karl Jablonowski, Ph.D., who co-authored the letter.

Hooker is CHD’s chief scientific officer Jablonowski is the senior research scientist.

The researchers found that different batches of the Pfizer Covid mRNA shots had very different rates of serious adverse events (SAEs).

Some of those batches, described as “hot lots” by the scientists, carried a far higher risk of death and injury for those who received them.

The “extremely high” amount of variability between batched proves that the shots “should have never been approved in the first place,” Hooker told The Defender.

Leading American cardiologist Dr. Peter McCullough blames the federal government’s emergency use authorization for the “hot lots.”

The authorization means vaccine makers aren’t required to have their final filled and finished vials inspected, McCullough noted.

Contaminants from the manufacturing process can be concentrated in certain lots.

Product transport, storage, and use issues also may affect particular lots.

For the CHD study, the researchers analyzed American vaccine lot data for the Pfizer-BioNTech vaccine.

This type of analysis allows researchers to track where the vaccine was manufactured and where it was distributed.

Informed Consent Action Network obtained the data in October 2022 through a Freedom of Information Act (FOIA) request.

The scientists matched that data to reports of adverse events in the Vaccine Adverse Event Reporting System (VAERS).

VAERS is the U.S. Centers for Disease Control and Prevention’s (CDC) passive reporting system where providers or recipients can report vaccine injuries.

It is not a complete inventory of all adverse events and is known to capture less than 1% of them.

The lot data showed that 410 million doses of the Pfizer-BioNTech vaccine produced in 156 different lots were distributed to 46,327 vaccine administration sites across the U.S. between Dec. 13, 2020, and April 26, 2022.

According to the data, on average 1,011,055 vaccines were distributed per day.

The vaccines came from between one and 10 different batches.

The number of doses produced in each batch varied widely — from 10,530 to over 11.8 million.

For the three years of data analyzed, 977,542 adverse events were reported to VAERS.

Of those, 455,820, or 46.7%, were related to the Pfizer-BioNTech mRNA “vaccines.”

However, only 29% of the reports included a batch number.

Among the 29%, 290,835 of the serious adverse events could be linked to the batch numbers in the Pfizer data.

The reports included a wide range of side effects:

• 78% of the adverse events reported weren’t serious.
• 20% were considered serious, meaning they required hospitalization or an emergency room visit or included a life-threatening event, permanent disability, or congenital malformation.
• 2% of the entries reported a death.

The researchers found that the adverse events were not distributed proportionally across the different lots.

The data reveals that some batches were associated with more side effects, and in some cases, significantly more.

Some of the Covid “vaccine” batches, particularly early ones, had higher rates of deaths and serious adverse events.

The rate of serious adverse events declined over time in all categories, the study found.

The researchers noted could be attributed to system management, fewer people reporting injuries, fewer injuries or those at a higher risk had already died or been injured.

The scientists said they expected to find a high number of deaths in states with the highest populations, such as California or New York.

However, they instead found that the proportions of serious injuries and deaths were relatively higher in places such as South Dakota, Kentucky, and Tennessee.

The research suggests that the dangerous batches had been sent to more rural communities rather than densely populated major cities.

The authors noted that data was only obtained through legal action.

Unsealing data through the courts makes this type of research far more challenging.

Also, the VAERS database is insufficient to capture all adverse events and regional variations within states, posing another challenge to understanding the full range of possible issues with the lots.

The paper is the latest in a series of papers to analyze vaccine lot and adverse event data by country.

Researchers in Denmark, the Czech Republic, and Sweden conducted similar studies with similar results.

CHD scientists built their analysis on work published by Danish researchers in 2023.

The scientists in Denmark analyzed Pfizer batch data associated with reported serious adverse events.

That Danish study analyzed data from Dec. 27, 2020, to Jan. 11, 2022.

The analysis found larger vaccine lot sizes were associated with fewer serious adverse events.

71% of the suspected adverse reactions occurred in 4.2% of the vaccine batches.

The study raised the alarm about safety issues associated with the vaccine production process.

The author of the Danish paper, Vibeke Manniche, M.D., Ph.D., told YouTube commentator John Campbell, Ph.D., that the study raised essential questions about Pfizer’s COVID-19 vaccine.

“Has the product changed?” Manniche asked.

“When did it change? Why did it change?”

That paper garnered significant negative attention in the press and on social media.

The authors described the backlash as “obsessive criticism” in the form of multiple responses from researchers attempting to discredit the study’s methodologies and interpretations.

The authors responded publicly in the European Journal of Clinical Investigation.

They defended their interpretations and said they “eagerly await more definitive studies of batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine, for example, from the SSI [Danish Statens Serum Institut], to refute or validate our results and increase the evidence base for this important area of research.”

In June, Czech researchers from the University of Ostrava and other research institutions reproduced the Danish study’s methodology.

They used Czech Republic data, released through a Freedom of Information Act request, from the beginning of the vaccination campaign through March 1, 2023.

They also analyzed adverse events reported after the COVID-19 vaccine by batch number.

They compared the reports to the results from the Danish registry data.

The Danish registry included data from Pfizer, Moderna, and AstraZeneca.

They similarly found that different batches had different rates of adverse events and that there were significantly higher numbers of adverse events associated with the early vaccine releases for all of the vaccines — “confirming the results of the study by Schmeling et al.”

Last month, the authors of the original Danish study expanded their analysis to Sweden and published their findings in the journal Medicina.

In that paper, the authors reported that the batch-dependent issues they identified in Denmark were confirmed in Sweden.

The Swedish scientists suggest that early commercial doses of Pfizer’s vaccine may have differed from later ones.

They concluded the issue merits further study.

The letter published today in Science, Public Health Policy and the Law similarly reproduced the Danish study’s methodology.

It made largely similar findings that there were clear variations in Pfizer’s lots and the patterns were similar.

The findings come as doctors, scientists, and researchers around the world are continuing to warn the public about global surges in deadly diseases and sudden deaths.

As Slay News reported earlier, a renowned American physician is sounding the alarm over skyrocketing numbers of young people being diagnosed with deadly cancers.

Dr. Cynthis Yoshida, a professor at the University of Virginia (UVA), warns that this troubling trend has now “become an epidemic.”

Meanwhile, leading experts in Japan have issued a red alert as the nation prepares to roll out the next generation of “self-amplifying” Covid mRNA “vaccines.” for public use, as Slay News reported.

They have just put out an emergency global warning as the nation is about to roll out the dangerous new “vaccines.”

A group of scientists and a top Japanese lawmaker have just held a press conference to warn the new “vaccines” will “trigger a worldwide disaster.”

READ MORE – Japan Links Covid Shots to 201 Dangerous Diseases